Apixaban has been developed in Minakem’s Canadian facility (Delmar Chemicals) in 2016. Regulatory wise, Minakem offers: – USDMF #30633 – CEP is expected in 2026 (Pharmacopea under evaluation). Minakem’s Apixaban … Learn More
503612-47-3
USDMF
GMP
USFDA audit
Nitrosamines
TSE/BSE
Non GMO
Hallal
Azaperone API is manufactured in Minakem’s French facility of Beuvry-la-forêt. Minakem owns a CEP since 2013.
1649-18-9
CEP
GMP
EDQM audit
Nitrosamines
TSE/BSE
Non GMO
Hallal
Bismuth valproate API is used to treat laryngitis.
60364-28-5
GMP
Budesonide API is micronised. Regulatory wise, Minakem offers: – USDMF #28441 – CEP #2010-90 – JDMF #301MF10045 – CDMF #Y20180001668 – Indonesian DMF Minakem’s Budesonide brings: – a selective PSD … Learn More
51333-22-3
Anti-Inflammatory
Anti-Allergic
Anti-Ashmatic
Gastro-Intestinal
CEP
USDMF
JDMF
CDMF
GMP
USFDA audit
EDQM audit
3rd party Audit report available (*)
Nitrosamines
TSE/BSE
Non GMO
Hallal
236395-14-5
USDMF
GMP
USFDA audit
Nitrosamines
TSE/BSE
Non GMO
Hallal
81161-17-3
USDMF
CDMF
GMP
USFDA audit
Nitrosamines
TSE/BSE
Hallal
217087-10-0
Anti-Ulcer
Gastro-Intestinal
Disorder Treatment
CEP
USDMF
GMP
USFDA audit
TSE/BSE
Non GMO
217087-09-7
Anti-Ulcer
Gastro-Intestinal
Disorder Treatment
CEP
USDMF
KDMF
CDMF
GMP
USFDA audit
EDQM audit
Nitrosamines
TSE/BSE
Non GMO
2321-07-5
CEP
USDMF
JDMF
GMP
USFDA audit
388082-77-7
USDMF
GMP
USFDA audit
Nitrosamines
TSE/BSE
Non GMO
Hallal
554-57-4
USDMF
USFDA audit
TSE/BSE
Non GMO
Hallal
223673-61-8
USDMF
GMP
USFDA audit
Nitrosamines
TSE/BSE
Non GMO
Hallal
140-64-7
CEP
USDMF
GMP
USFDA audit
Nitrosamines
TSE/BSE
Non GMO
Hallal
98-96-4
USDMF
GMP
USFDA audit
TSE/BSE
Non GMO
Hallal
132875-61-7
Analgesic/sedation
CEP
GMP
EDQM audit
Nitrosamines
TSE/BSE
85409-38-7
ASMF
GMP
Nitrosamines
TSE/BSE
Non GMO
Hallal
242478-37-1
CEP
USDMF
GMP
USFDA audit
Nitrosamines
TSE/BSE
Non GMO
Kosher
2056030-06-7
71-27-2
USDMF
GMP
USFDA audit
Nitrosamines
TSE/BSE
Non GMO
Kosher
540737-29-9
USDMF
GMP
USFDA audit
Nitrosamines
TSE/BSE
Non GMO
Hallal